Lupin to approach USFDA for reinspection of key plants in next few months

Read more

Regular dose of aspirin can lower risk of inherited bowel cancer: Study

Read more

Phenomenex introduces bioZEN, a 2.6 µm WidePore C4 core-shell LC

Read more

Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management

Read more

BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir

Read more

Cancer CART therapy: What are the benefits and stakes?

Read more

Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir

Read more

Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK + BLU-U Data for skin cancer treatment

Read more

Pharma MSMEs ask government to extend incentives of PLI scheme

Read more

Lupin ties up with Omron Healthcare

Read more